NVS
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Oct 2025)
What this means for you
This application is over — abandoned 01 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97774873
- Mark type
- Design + words
- Filed
- 31 Jan 2023
- Published for opposition
- 24 Oct 2023
- Abandoned
- 01 Oct 2025
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
Owner
- Novelstar Pharmaceuticals Inc., Cranbury, NJ, US
- Novelstar Pharmaceuticals Inc., Cranbury, NJ, US
Prosecution history
- 01 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2024 — SOU EXTENSION 1 GRANTED
- 13 Jun 2024 — SOU EXTENSION 1 FILED
- 13 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2023 — PUBLISHED FOR OPPOSITION
- 04 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED